News & Events
Read about the latest developments at NorthX Biologics and find out more about relevant happenings in the industry.
Welcome to a unique conference experience in Northern Sweden on the 27th and 28th of September!
Nordic Conference and Opening Ceremony of NorthX Innovation Hub Welcome to a unique conference experience in Northern Sweden. Here you will meet the frontrunners of Advanced Biologics and get acquainted with ...
Nordic Life Science Days 2023
29-30 November, Copenhagen, Denmark. Nordic Life Science Days is the largest Nordic partnering conference dedicated to the life science industry. Since its inception in 2013, the event has nurtured a community of ...
Bio Europe 2023
November 14–15, Munich, Germany. BIO-Europe convenes over 5,000 attendees, representing 60 countries and 2,220+ companies, making the event the industry’s largest gathering of biopharma professionals in Europe. More info here. Come see ...
World Vaccine Congress Europe 2023
17 – 19 October 2023 in Barcelona, Spain In its 24th annual edition, the World Vaccine Congress Europe will bring experts from the whole value chain under one roof, where ...
Meeting on the Mesa 2023
Cell & Gene Meeting on the Mesa on October 10-12 in Carlsbad California. The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior ...
NorthX Biologics acquires the Stockholm-based Clinical Trial Manufacturing unit from Valneva Sweden
NorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva MATFORS, Sweden, July 03, 2023 (GLOBE NEWSWIRE) NorthX Biologics (‘NorthX’), a leading ...
Covid-19 vaccine that can cope with mutated viruses in clinical phase 1 study at Karolinska University Hospital
A new DNA-based vaccine against covid-19 is being tested for the first time on healthy participants at Karolinska University Hospital. The vaccine has been developed at Karolinska Institutet and target ...
Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB (“NorthX”). NorthX ...
NorthX Biologics enters as a partner in AdBIOPRO, Competence Centre for Advanced BioProduction
NorthX Biologics is proud to have the opportunity to support and be a part of AdBIOPRO. “It is a great infrastructure for ground breaking research and development aimed at finding ...